Cardiovascular magnetic resonance (CMR) is an indispensible clinical tool that can identify the etiology of cardiomyopathy. Unlike other non-invasive imaging modalities, CMR leverages its intrinsic capacity to characterize tissue based upon fundamental MR properties (T 1 and T 2 ) and in so doing can differentiate normal from diseased myocardium. Following the administration of the exogenous contrast agent gadolinium, which is retained in areas of increased interstitial space, intrinsic MR differences are accentuated permitting selective visualization of fibrosis and infarction by means of late gadolinium enhancement (LGE).
LGE, arguably one of the most important innovations in the history of CMR, works best when the border between normal and abnormal is distinct and the region of abnormality is sufficiently different so as to result in significant gadolinium accumulation, thereby shortening T 1 and rendering a high signal intensity difference from normal myocardium.
In diffuse myopathic processes, as typified by cardiac amyloidosis, the discriminative capacity of LGE to differentiate the normal from the abnormal is challenged because the entire myocardium is abnormal and clear demarcation is absent. In cardiac amyloidosis, precursor proteins pathologically unfold to form amyloid fibrils that deposit in the myocardium thereby increasing interstitial space and resulting in gadolinium accumulation. While it is generally accepted that the most common types of cardiac amyloidosis, light-chain (AL) and transthyretin (ATTR), overlap in respect to their CMR manifestations 1, 2 , there are no reported data to effectively disentangle amyloid type and degree/stage of amyloid infiltration. For this reason, reported LGE characteristics in cardiac amyloidosis are quite varied, with diffuse, subendocardial and transmural patterns reported 3 . Furthermore, standard LGE imaging techniques are flawed in amyloidosis as there is a requirement that the MR technologist select a key parameter from visual inspection, the inversion time (TI), to optimally suppresses signal ignificant gadolinium accumulation, thereby shortening T 1 and rendering a high s s sig ig igna na nal l l in in inte te tens ns nsit i i y difference from normal myocardium.
In Diffuse myocardial processes are perhaps better assessed by CMR through T 1 mapping techniques that estimate the myocardial T 1 tissue relaxation time in a pixel-wise manner to create a T 1 map. T 1 maps measured before (i.e. native T 1 map) and after gadolinium contrast can be used to non-invasively assess the myocardial extra-cellular volume fraction (ECV). Compared to controls, abnormal T 1 and ECV differences have widely been described in various cardiomyopathies including hypertrophic, non-ischemic dilated, and amyloid 4, 5 . In practice,
LGE is relatively simple to perform and interpret while T 1 /ECV is not owing to heterogeneity of acquisition and post processing techniques; however, performed correctly, the two techniques measure the same T 1 variation albeit with different contrast-to-noise ratio, and thus regions of
LGE should correspond spatially to abnormal T 1 /ECV mapped areas.
In this issue of Circulation, Fontana et al. present a complete report of both T 1 /ECV mapping and LGE among patients with cardiac amyloidosis 6 . This study, the largest series of CMR in cardiac amyloidosis yet reported, redefines our understanding of the continuum of infiltration in cardiac amyloidosis from early to late stage of disease, and moves beyond a simple dichotomous interpretation of imaging information. The application of LGE and T 1 /ECV mapping in the same dataset unifies contemporary non-invasive CMR assessment with hard clinical outcomes for the first time, and importantly, supports the use of a widely available LGE technique, phase sensitive inversion recovery (PSIR), as the most accurate means by which to assess LGE in amyloidosis. The PSIR sequence removes the subjective TI selection variable from LGE imaging acquisition thereby improving identification of hyperenhancement and eliminating the possibility of confounding by the wrong choice of TI. The implications of this acquisition and post processing techniques; however, performed correctly, the two wo wo t t tec ec echn hn hniq iq ique ue ues s s measure the same T 1 variation albeit with different contrast-to-noise ratio, and thus regions of
LGE E E sh sh shou ou ould ld ld c c corr r res s spond spatially to abnormal T 1 1 1 /E /E /ECV C C mapped areas. The principal findings of this report are as follows. First, there appeared a continuum of amyloid accumulation as determined by LGE pattern progressing from normal to transmural, the latter being more prevalent in ATTR, with robust ECV cut-points that were not specific to amyloid type. Second, utilizing a subset of 100 patients with post-contrast T 1 maps as the "truth standard" for contrast accumulation in areas of presumptive amyloid deposition, the PSIR technique proved superior to conventional MAG-IR for accuracy in assignment of LGE pattern.
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Discordance between MAG-IR and PSIR was high (57%), an impressive observation given the classification scheme (normal, sub-endocardial, transmural) while associating the e e ob ob obse se serv rv rved ed ed L L LGE G G pattern with ECV and clinical outcomes. In this way, they were able to compare standard MAG-R w w wit it ith h h PS PS PSIR IR IR, AL AL AL with TTR, and early with adva va vanc nc nced disease. The pati ti ien n nts were also ch ch char ar aracterized d by by by ech ch hoc oc ocar ar ardi di diog og ogra ra raph ph phy y y (t (t (tho h h u ugh h h no no otably y y wi i ith th thou ou ut t t lo l l ng ng ngit t tud ud udin in na a al sys sto to toli li lic c st st stra ra rain n n) ) ) an an and This study greatly informs our understanding of how amyloid cardiomyopathy progresses from early to advanced stage of infiltration while affording insight into conflicting prior reports of LGE and its relationship to survival. One important observation consistent with prior reports is that among patients with transmural LGE, associated with the highest ECV and worst prognosis, myocardium retained more gadolinium than the blood pool causing blood pool signal nulling and rendering the myocardium uniformly bright (termed diffuse hyperenhancement) 7 . It is also notable that LGE pattern predicted survival irrespective of amyloidosis type, although this appeared most striking in AL. Given this high discordance of PSIR from MAG-IR, the high concordance of PSIR with post-contrast T 1 maps, and comparative simplicity and wide-spread availability of PSIR, the authors concluded that PSIR should replace MAG-IR as the LGE method of choice in cardiac amyloidosis.
It is important to note that the methodology used to assess discordance between T 1 maps, PSIR, and MAG-IR LGE was non-standard. The use of post-contrast T 1 as the "truth standard" method for visualization of extracellular space expansion is clearly challenging and subjective in cardiac amyloidosis. The low image contrast between amyloid infiltrated and healthy from early to advanced stage of infiltration while affording insight into conflicting ng ng p p pri ri rior or or r r rep ep epor or ort t ts of LGE and its relationship to survival. One important observation consistent with prior reports s tha ha at t t am am amon on ong g g pa a ati ti tie e ents with transmural LGE, ass soc oc ocia ia iated with the highest st st E E ECV and worst p p prog g gnosis, myo o oc c car rdiu iu um m m re re reta ta tain in ned ed ed m m mo or ore e ga ado doli l l n ni n um m t th han n n t t the he he b b blo l l od od od p p poo ool l l ca ca c usin n ng g g bl bl bloo oo ood d d po po po l ol l s s sig ig igna na nal nu u ull ll l in in ing g and re re rend der er erin i g th h he my y yoc c car a di di dium um um u u uni n fo fo orm m mly br r righ h ht (t (ter er rme me med d di i iff f fus u u e e e h hype pe pere re renhan an anc c cem men n nt) 7 . . . It s s s a a als ls lso o o no no nota ta tabl bl ble e e th th that at at L L LGE GE GE p p pat at atte te tern rn rn p p pre re redi di dict ct cted ed ed s s sur r urvi i viva a val l l ir ir irre re resp sp spec ec ecti ti tive e ve of of of a a amy m mylo lo loid id idos os osis is is t t typ p ype e e, a a alt lt ltho ho houg g ugh h h th th this is is s myocardium renders accurate detection difficult. T 1 measurements were performed using the shortened modified look-locker inversion recovery sequence (ShMOLLI) with regions of interest (ROI) drawn in the 4 chamber view at the level of the basal and mid inferoseptum. It is unclear whether the authors included or excluded areas of enhancement on LGE in these ROI for postcontrast T 1 measurements, which may have biased ECV calculations. In addition, the T 1 maps presented appear to be scaled to a broad T 1 range (300 -3300 ms) rendering it difficult to visually identify the myocardial regional differences of up to 150 ms the authors report.
Furthermore, this study utilizes an equilibrium ECV and post-contrast T 1 measurement that is rather cumbersome and somewhat out-dated. The equilibrium technique may not add additional information compared to single bolus infusion, now more commonly used in CMR studies to measure ECV. In respect to LGE transmurality assignment, it will be important to demonstrate reproducibility in a multi-center cohort given the acknowledged challenging image quality.
Finally, the limited subgroups size (PSIR vs. non-PSIR, TTR vs. AL) rendered relatively wide confidence intervals, particularly for the key association between transmural LGE and survival.
It is also notable that among the ATTR patients, those with wild-type TTR and variant (mutated) TTR were included in the same ATTR categorization. This combination of potentially different disease trajectories may be problematic for survival interpretation. In respect to amyloid deposition however, the data do suggest that DPD uptake, LGE transmurality, and ECV are all nformation compared to single bolus infusion, now more commonly used in CM M MR R R st st stud ud udie ie ies s s to to to measure ECV. In respect to LGE transmurality assignment, it will be important to demonstrate epr rod od oduc uc ucib ib ibil il ilit it ity in n n a a a multi-center cohort given th he e e ac ac acknowledged challen n ngi g g ng image quality.
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While a large series, cardiac amyloidosis was determined without cardiac biopsy in the vast majority of AL patients (94%) and most of the ATTR patients (71%), the latter of which were typically identified by DPD scintigraphy. This reflects the expertise and clinical practice of this referral center, and is not dissimilar from other reports 8 . Furthermore, while we are provided with treatment regimens for AL disease and hematologic response status in broad terms, we are not provided with specific information such as free light chain or cardiac troponin concentrations, that might help elucidate the component of direct toxicity of pre-fibrillar light chain proteins in respect to ECV and LGE. Finally, as is intrinsic in all contrast-enhanced CMR studies, patients with advanced renal disease (glomerular filtration rate < 30 ml/min) were excluded, thereby affording a selection bias. For patients with advanced renal disease, native T 1 mapping (data provided here in Table 2 ), may provide useful prognostic and diagnostic mapping (data provided here in Table 2 ), may provide useful prognostic and diagnostic nfo orm rm rmat at atio io ion n n 9 . . .
While ar ar argu gu g ab b bly ly ly r r red ed edef ef efin in inin in ing g g th th the CM CM C R R R as s ssessm m men n nt t t of of of c c ca ar ardi di diac a a a amy my mylo l loidos s sis is is, ho ho how w w do do does es s o o one ne ne n n nco co corp rp rporate th th the f fi f n nd n ings gs gs of F Fo Font nt ntana a a e et e a a al. . int t to th t e la ar rge e er c con n ntex ex ext t of of of cli li lini i ica al as as asse e essme me men nt n in n y yst st stem em emic ic ic a a amy m mylo lo loid id id d d dis is isea ea ease se se? ? ? Fo Fo For r r AL AL AL d d dis is isea ea ease se se i i in n n pa pa part rt rtic ic icul l ular ar ar, gi gi give e ven n n th th the e e we e weal al alth th th o o of f f da da data ta ta s s sup p uppo po port rt rtin in ing g g utility of CMR in cardiac amyloidosis. These data strongly suggest that PSIR should replace MAG-IR for LGE determination in cardiac amyloidosis, and that T 1 mapping (however, we would submit using a contrast bolus rather than equilibrium technique) affords insight into the continuum of amyloid fibril deposition that occurs in this disease. We commend the authors on their accomplishment and anticipate that these conclusions will refine clinical practice.
